Brandi Glanville rushed to hospital after frantic 911 call amid facial parasite battle
Brandi Glanville was rushed to the hospital on Wednesday amid her battle with a mysterious illness that caused striking facial disfigurement.
The former Real Housewives of Beverly Hills star, 52, revealed she called 911 after being unable to move her head and neck for hours, preventing her from getting out of bed.
The reality TV star — who believes the skin condition that has left her visage disfigured was caused by a parasite — also posted photos from the hospital while hooked up to IVs.
'My head and neck would not move for four hours this morning. I could not get out of my bed,' she wrote on X.
'I called 911 had a lovely trip in the ambulance now I am at this amazing place after sitting in a wheelchair in the waiting room for four hours.'
The star also shared a photo of a Kaiser Permanente form in a separate post, with the caption, 'I hate this place but should be another fun ambulance bill.'
Last week, Glanville updated followers that she has seen no improvement in her battle with the facial disfigurement.
She shared a photo of a tub filled with brown liquid, explaining it was drainage from her face that's causing various health issues.
'The clear plaque sitting on top like oily wax is produced all day by my face,' she wrote.
'It drains down, eroding my teeth. I can't see & have 2 hard lumps under my left cheek bone. 1 on back of neck & jawbone. I need infectious disease Dr. that specializes in fungal infections? HELP.'
Brandi — who has spent more than $70,000 trying to get better — also complained of having 'chills' and added that 'all of my lymph nodes in head [and] neck are swollen.'
At the time she wrote, 'Doctors at Kaiser [Permanente] say I'm fine.'
Days prior, the reality star revealed she'd been 'faking it' with her seemingly happy demeanor and she's actually been 'f***ing miserable.'
'My face is worse than ever. It's literally melted away,' Glanville tweeted.
'My head and neck would not move for four hours this morning. I could not get out of my bed,' she wrote on X
'I hate this place but should be another fun ambulance bill,' she wrote in the caption
'When doctors at [Cedars-Sinai Medical Center] put me on IV antibiotics [and] fungal medication I was getting better. I looked normal, but I couldn't afford to stay on them. I was forced to see doctors outside my insurance because the doctors at Kaiser had no clue. I need my life to change. That is my real life health update.'
In January, Botched star Terry DuBrow took 'four tiny biopsies' from the Unfiltered podcaster's face and neck after steroids, antibiotics, and antiviral medication failed to help her.
When X user @caren_0809 asked about Brandi's biopsy report last Thursday, she replied: 'No cancer but the cultures take six weeks to grow so no news yet but [fingers crossed].'
On December 12, the 66-year-old plastic surgeon informed Glanville through TMZ that her disfigurement was not the result of a 'parasite' but a 'foreign-body reaction to something she had injected' and it would take five years to fully recover.
'Five years is way too long for me to wait,' the Traitors contestant scoffed on her podcast at the time.
'I have s**t to do. I have places to go, people to make out with. I have not had sex since last October [2023]. I haven't kissed [or] made out with anyone. I haven't socialized, really.'
Back in February, Glanville was seen using a small red light device on her face amidst filming her Unfiltered podcast with co-host James Maas.
She was seen rolling the device on her neck while talking as red lights shone on to her skin. It is not known what the device is or what it is used for.
However, Glanville did reveal that her use of the red light device is relating to her mystery skin condition during a recent Instagram Live.
When a fan asked her if the 'worm' was gone, after she said it could be an infection or parasite, she replied: 'The worm is not gone, that is why I'm using this [device].'
Late last year, Glanville admitted on Page Six's Virtual Reali-Tea podcast that she has been suffering from 'deep depression' amid her battle with the mysterious skin condition.
'The pain is more mental than anything, because I have been hiding and going through a deep, deep depression. Even if I could work now, at this point, I couldn't. So it's just been a really rough two years for me.'
She added at the time that she was also on antibiotics - which she had briefly stopped and caused the skin on her face to 'sink in.'
Glanville said: 'I prefer [my face] when it's a little swollen, to be honest. When it's only swollen on one side, it's not great. But the sinking in thing is killing me slowly, because I just feel like I look like a crackhead.'
The TV personality said that she sometimes will wear a 'mask' around her sons and explained, 'They would try and calm me down and say I look normal and fine, but I knew better.
'I honestly scared them a couple times. They were like, "What is happening?" [My face] went from being like really fat and swollen to now, like, sinking in.'
Glanville added that she wants to know what is causing her facial disfigurement 'so desperately.'
She noted: 'You could do anything you want to me, and I'd be okay with it. I've had days of looking normal, not weeks. I wish. But it comes and goes.'
She then stated, 'Whenever I get the chills, it's generally an infection. Then I start having the ticking in my ear, and then whatever's in my face, moving around, started moving around again. And it starts sinking in again.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
28-05-2025
- Reuters
Kaiser Permanente says it is facing intermittent network disruptions
May 28 (Reuters) - Healthcare conglomerate Kaiser Permanente said on Wednesday it is facing intermittent network disruptions affecting several of its systems, including electronic health records and patient services. The outage has impacted online features such as e-visits, billing, messaging and access to medical records, the company said, adding that some pharmacy, lab, radiology and call center operations are also experiencing delays. "Our technical teams are engaged and working to resolve this issue as quickly as possible," Kaiser Permanente said. The company said it has backup systems and procedures in place to support continuous patient care and secure access to medical records.
The Sun
03-05-2025
- The Sun
Scientist bitten by deadly snakes 200 TIMES helps create ‘unparalleled' anti-venom to save thousands of lives
A WACKY scientist has allowed the world's deadliest snakes to bite him over 200 times to help create an "unparalleled" anti-venom. Tim Friede has been injected by snake toxins over 850 times across his 18-year career and once even fell into a coma due to two cobra bites. 6 6 6 Snake venom kills up to 140,000 people each year and can leave over 420,000 people needing life altering amputations. The cases remain so high due to their being no universal antivenom against all snakebites. But after nearly two decades of death-defying work, Tim's research may have finally paid off. His fearless antibodies have been shown to protect against fatal doses from a wide range of dangerous species in recent animal tests. The American initially allowed himself to be bitten to help further his career on YouTube where he handled a range of snakes. He believed it would help him build up an immunity to protect himself when finding some of the world's worst snakes. His bizarre plan once left the former truck mechanic fighting for his life after two Egyptian cobra bites in quick succession left him in a coma for days. Tim told the BBC he "didn't want to die" and so when he awoke and was back to full health he used his second chance at life to help others survive. He explained: "It just became a lifestyle and I just kept pushing and pushing and pushing as hard as I could push for the people who are 8,000 miles away from me who die from snakebites." His brave work was soon noticed by research teams who got in contact and asked to examine his blood. The team of scientists were searching for a type of immune defence which had neutralised antibodies - something they believed Tim may have developed. Dr Jacob Glanville, chief executive of biotech company Centivax, reached out to him and asked if they could take a blood sample for testing. Tim soon agreed after he was told his body has been able to repel venom which would "normally kill a horse", according to Dr Glanville. The research focused on two families of venomous snakes which included coral snakes, mambas, cobras, taipans and kraits. These reptiles use neurotoxins in their venom to paralyse their victim to the point where their muscles can no longer supply the body with enough oxygen. Researchers handpicked 19 of these creatures which are considered as being among the deadliest snakes on the planet. Soon after analysing Tim's blood they uncovered two broadly neutralising antibodies that target neurotoxins, according to their work which is detailed in the journal Cell. A third drug was later added to the antivenom cocktail before it was used on mice. 6 6 Out of 19 test subjects, 13 survived lethal doses of snake venom. The remaining six were found to have partial protection against the poison. Dr Glanville described the results as "unparalleled" in the current world of antivenom research. He also believes this means the cocktail will likely cover a whole range of other snakes. The team is now trying to see if they can add a fourth component to the drug mixture in order to offer full protection to venom. Currently, testing has only been done on elapid snake venom which covers the two most common families of deadly snakes. The other major snake types which contribute to global death rates are vipers. Tim's antibodies are really quite extraordinary - he taught his immune system to get this very, very broad recognition Professor Peter KwongColumbia University They use haemotoxins to attack blood cells rather than neurotoxins which target muscles - a key difference to elapids. But Professor Peter Kwong, a researcher at Columbia University, believes the initial results prove that one day a complete antivenom will be discovered. He said: "I think in the next 10 or 15 years we'll have something effective against each one of those toxin classes." The ultimate goal is to create a single antivenom or discover two injections which cover elapids and vipers. And Tim is planning on helping out for as long as he can. He said: "I'm doing something good for humanity and that was very important to me. I'm proud of it. It's pretty cool." Prof Kwong says his team owes Tim and the world a huge thank you for what he has put his body through for science. "Tim's antibodies are really quite extraordinary - he taught his immune system to get this very, very broad recognition," he said. The team are now preparing to test its antivenom cocktail in Australia on dogs who have been bitten by a snake. 6
The Guardian
02-05-2025
- The Guardian
Snake collector's immunity quest opens path towards universal antivenom
He has self-administered more than 850 doses of venom from cobras, mambas, rattlesnakes and other deadly species in pursuit of a singular quest: to develop immunity to snake bites in the hope of helping scientists create a universal antivenom. Now the extreme 18-year experiment by Tim Friede, a former truck mechanic from Wisconsin, appears to have paid off. Scientists have used antibodies from his blood to create the most broadly protective antivenom to date, which could revolutionise the treatment of snake bites. 'For a period of nearly 18 years, [Tim] had undertaken hundreds of bites and self-immunisations with escalating doses from 16 species of very lethal snakes that would normally a kill a horse,' said Jacob Glanville, the chief executive of the US biotech Centivax and first author of the research. 'It blew my mind. I contacted him because I thought if anyone in the world has these properly neutralising antibodies, it's him.' The cocktail, which combines two protective antibodies from Friede's blood and a small molecule venom inhibitor, opens a path towards a universal antivenom, according to research published in the journal Cell. This could transform the ability to treat snake bites, which cause about 140,000 deaths and 300,000 permanent injuries each year. Most antivenoms rely on a 100-year-old method that involves immunising horses or sheep with venom from single snake species and collecting the antibodies produced. While effective, there is a risk of severe adverse reactions, including anaphylaxis, to the non-human antibodies. And treatments tend to be species- and sometimes region-specific. 'I grew up in Guatemala and they recommend you try to catch the snake and bring it in in a plastic bag so they can determine if they have an appropriate antivenom,' Glanville said. 'It's not a great option to go chasing after the snake that's just bitten you.' Friede, aware of the shortcomings of antivenoms and hoping to fortify himself against accidental bites from his collection of pet snakes, embarked on his self-immunisation quest in 2000. Despite spending four days in a coma in 2001 after being bitten while milking an Egyptian cobra, he continued with his meticulous dose escalation programme, injecting low doses of venom from 16 lethal species before offering up his arms to the snakes to bite. When Glanville came across an article about Friede, who had documented his project on his YouTube channel, he got in touch. 'He was like: 'Finally. I've been waiting for this call for a long time,'' Glanville said. To design the antivenom, the team selected 19 of the World Health Organization's category 1 and 2 deadliest species, including coral snakes, mambas, cobras, taipans and kraits. After isolating candidate antibodies from Friede's blood, they tested these out in mice envenomated from each species. This allowed them to identify just two antibodies that, when combined with a synthetic antivenom, provided complete protection against 13 of the species and partial protection against the others. 'By the time we reached three components, we had a dramatically unparalleled breadth of full protection for 13 of the 19 species and then partial protection for the remaining that we looked at,' Glanville said. He said Friede's meticulous dosing schedule, which involved cyclical exposure to different venoms, meant that any antibodies that offered broader protection were boosted more frequently and were amplified by his immune system. 'Had I, as an immunologist, spent a bunch of time thinking about it, I don't think I would have come up with a better solution,' he said. Snakes fall into four major families, two of which – elapids and vipers – account for the dangerous venomous species. The current research focused on elapids, but Friede also immunised himself against viper bites and the team are developing an equivalent antivenom cocktail for the viper family. The team are now looking to test the efficacy of the antivenom in the field, initially in dogs brought to veterinary clinics for snake bites in Australia, before moving to human trials. Prof Nicholas Casewell, the director of the Centre for Snakebite Research at Liverpool School of Tropical Medicine, who was not involved in the research, said: 'This breadth of protective benefit is certainly novel, and provides a strong piece of evidence that combining relatively few antibodies and or drugs together is feasible as a therapeutic strategy and could lead to a future therapy that could be beneficial to snakebite patients in many different parts of the world. There is no doubt that this work moves the field forwards in an exciting direction.'
